During the past decade, UCSF Investigational Drugs Pharmacy conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "UCSF Investigational Drugs Pharmacy" are "HR+ HER2- Metastatic Breast Cancer, Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer, Triple Negative Breast Cancer, Male Breast Cancer" (1 trials) and "Neoplasm Metastasis" (1 trials). Many other conditions were trialed in "UCSF Investigational Drugs Pharmacy" in a lesser frequency.

Most popular intervention types in "UCSF Investigational Drugs Pharmacy" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Axitinib" (1 trials), "Endocrine Therapy 1" (1 trials), "Endocrine Therapy 2" (1 trials), "PF-06873600" (1 trials) and "PF-07265807" (1 trials). Other intervention names were less common.

The vast majority of trials in "UCSF Investigational Drugs Pharmacy" are 2 trials for "All" genders.

Currently, there are NaN active trials in "UCSF Investigational Drugs Pharmacy". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in UCSF Investigational Drugs Pharmacy, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in UCSF Investigational Drugs Pharmacy, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".